Machine learning-guided QSAR screening of fluconazole analogs and FDA-approved drugs against Candida albicans, with docking, molecular dynamics, and ADMET analysis.

Daudo HA, Marinho ES, de Oliveira VM, Marinho MM, Ribeiro RV

Open source

DOI
10.1007/s11030-026-11621-3
Published
2026 Aug 7
Container
Molecular diversity
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s11030-026-11621-3,
  title = {Machine learning-guided QSAR screening of fluconazole analogs and FDA-approved drugs against Candida albicans, with docking, molecular dynamics, and ADMET analysis.},
  author = {Daudo HA and Marinho ES and de Oliveira VM and Marinho MM and Ribeiro RV},
  year = {2026},
  journal = {Molecular diversity},
  doi = {10.1007/s11030-026-11621-3},
  url = {https://doi.org/10.1007/s11030-026-11621-3}
}

RIS

TY  - JOUR
TI  - Machine learning-guided QSAR screening of fluconazole analogs and FDA-approved drugs against Candida albicans, with docking, molecular dynamics, and ADMET analysis.
AU  - Daudo HA
AU  - Marinho ES
AU  - de Oliveira VM
AU  - Marinho MM
AU  - Ribeiro RV
PY  - 2026
JO  - Molecular diversity
DO  - 10.1007/s11030-026-11621-3
UR  - https://doi.org/10.1007/s11030-026-11621-3
ER  - 

APA

HA, D., ES, M., VM, D. O., MM, M., & RV, R. (2026). Machine learning-guided QSAR screening of fluconazole analogs and FDA-approved drugs against Candida albicans, with docking, molecular dynamics, and ADMET analysis.. Molecular diversity. https://doi.org/10.1007/s11030-026-11621-3

Source records